High serum microRNA-122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients
Authors:
- 1 February 2015
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 36 (6) , 4773-4776
Abstract
Previous studies have shown that some microRNAs (miRs) are intensively involved in the development of hepatocellular carcinoma. We analyzed the prognostic role of serum microRNA (miR-122) levels in hepatocellular carcinoma patients using a retrospective design. MiR-122 levels in 122 hepatocellular carcinoma patients were measured, and Cox regression analysis was performed to analyze the prognostic role of miR-122 in hepatocellular carcinoma, and the hazard ratio (HR) with 95 % confidence interval (95 %CI) was used to evaluate its prognostic role. Patients with large tumor size had lower levels of serum miR-122 (P = 0.04). However, there was no significant association of serum miR-122 levels with other clinical characteristics. Kaplan-Meier method showed that there was higher overall survival rate in hepatocellular carcinoma patients with high serum miR-122 levels compared with those with low miR-122 level (P < 0.01). When using Cox regression analysis, high serum miR-122 level was independently associated with better overall survival in hepatocellular carcinoma patients (HR = 0.26; 95 %CI 0.14–0.47, P < 0.01). Subgroup analysis by gender showed that high serum miR-122 level was independently associated with better overall survival in male patients (HR = 0.08; 95 %CI 0.03–0.22, P < 0.01), but not in female patients (HR = 0.48; 95 %CI 0.18–1.32, P = 0.16). Thus, the outcomes in the analysis suggest that high serum miR-122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients, and it is a good biomarker of better prognosis in patients with hepatocellular carcinoma.Keywords
This publication has 25 references indexed in Scilit:
- Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetesThe Lancet Diabetes & Endocrinology, 2014
- The Role of MicroRNAs in the Control of Innate Immune Response in CancerJNCI: Journal of the National Cancer Institute, 2014
- Regulation of microRNA function in somatic stem cell proliferation and differentiationNature Reviews Molecular Cell Biology, 2014
- MicroRNAs in cancer: biomarkers, functions and therapyTrends in Molecular Medicine, 2014
- Regulation of microRNA biogenesisNature Reviews Molecular Cell Biology, 2014
- Regulation of gene expression by microRNA in HCV infection and HCV–mediated hepatocellular carcinomaVirology Journal, 2014
- The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysisThe Lancet Diabetes & Endocrinology, 2014
- Hepatitis B Virus mRNA-Mediated miR-122 Inhibition Upregulates PTTG1-Binding Protein, Which Promotes Hepatocellular Carcinoma Tumor Growth and Cell InvasionJournal of Virology, 2013
- MicroRNA-122-dependent and -independent replication of Hepatitis C Virus in Hep3B human hepatoma cellsVirology, 2013
- MicroRNA‐122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β‐catenin pathwayLiver International, 2012